Shuchi Nahar's Weekend Blog!

  Laurus Labs Ltd. –Story of Patience, diligence, and perseverance Twitter Handle: @shuchi_nahar Link to Company Overview of Laurus Labs in detail: https://myweekendspot.blogspot.com/2020/09/laurus-labs-company-overview.html Result Update – Q3FY21 Laurus Lab performed extremely well consecutive in the 3 rd  quarter of FY21. The company did a robust growth in all three segments. Having   a healthy order book for FY 21 & beyond in FDF CMO business with a strategic partner in EU. Consolidated revenue for the quarter increased by 76% driven by growth in all the divisions. The company has been able to sustain its EBITDA margins, and profitability has also improved to Rs. 273 Crs. for the quarter. The generic API division recorded a healthy growth of over 100% for the quarter, the growth was led by higher growth in ARV API business in turn led by higher volume of 1st line products. The Formulations business showcased a growth of over 120% for the 9M period, led by higher LMIC bus

Laurus Labs : Company & Business Overview Shuchi.P.Nahar Twitter:  @shuchi_nahar  1.   Company Profile & Background Laurus Labs is a leading R&D driven pharmaceuticals company established in 2005 with its headquarters in Hyderabad. It is among the leaders in the manufacturing of Active Pharmaceutical Ingredients (APIs) for Antiretroviral (ARV) and Hepatitis C (Hep-C) formulations. Other major API segments include therapeutic areas such as Oncology, Cardiovascular, and Anti-Diabetes. ·        From a one-product company in 2010 to an Active Pharmaceutical Ingredients (APIs) company thereafter, company has now emerged as one of India’s leading manufacturers of generics APIs for various complex therapies. ·        Company is thriving on growth opportunities in formulation manufacturing, addressing the critical needs of the world’s key pharmaceutical markets. ·        Over the years, the most important enablers of this transformation has been their People, Plants, Products, and

A Masterclass on Global Custom Development & Manufacturing Opportunity  Shuchi.P.Nahar To understand what are CDMO,CRAMS,API etc or what will drive pharma sector growth ?Do read my previous articles for brief understanding.... Link:  https://myweekendspot.blogspot.com/2020/05/which-segment-of-pharmaceutical-company.html https://myweekendspot.blogspot.com/2020/05/understanding-pharma-growth-from.html https://myweekendspot.blogspot.com/2020/05/what-will-drive-pharma-sector-growth.html https://myweekendspot.blogspot.com/2020/03/pharmaceutical-industry-10-years-future.html https://myweekendspot.blogspot.com/2020/01/good-fortune-for-pharma-sector.html CDMO Industry Insight The global pharmaceutical contract manufacturing & contract research market size was valued at over USD 123.1 billion in 2016. Cost saving and time saving benefits associated with the implementation of outsourcing is responsible for driving the industrial growth. Companies are investing in infrastructure, pe